Of the 20 pathways, lipid and atherosclerosis, JAK-STAT signaling pathway, AGE-RAGE signaling pathway, and toll-like receptor signaling pathway may be related to the potential mechanism of hydroxychloroquine for IgAN treatment (Fig. 2D). The gene discussed is SOAT1; the disease is atherosclerosis.